ABSTRACT
Thrombocytopenia (rise of the thrombopoietin level) was induced by an antithrombocyte serum in mice. After 6 hours of existence of thrombocytopenia, the CFU-S and megakaryocyte-commmitted stem cell content of the bone marrow and spleen was determined by transplantation into mice pretreated with 800 cGy-rtg irradiation. Thrombocytopenia did not influence the CFU-S content. Thrombocytopoiesis of the recipient mice was better restored by bone marrow and spleen cells of thrombocytopenic animals than by cells transplanted from animals with a normal thrombocyte count.
Subject(s)
Blood Platelets/pathology , Bone Marrow/pathology , Glycoproteins/physiology , Hematopoietic Stem Cells/pathology , Spleen/pathology , Thrombocytopenia/blood , Thrombopoietin/physiology , Animals , Bone Marrow Transplantation , Colony-Forming Units Assay , Megakaryocytes/pathology , Mice , Platelet Count , Spleen/transplantation , Thrombopoietin/metabolismABSTRACT
The thrombopoietic serum activity was examined in rats during thrombocytopenia produced by bleeding or after treatment with antithrombocyte serum (ATS). 6 hours after both treatments the thrombopoietic activity of the serum, i.e. its content of thrombopoietin, is increased. After the ATS treatment of nephrectomized animals a similar increase of thrombopoietic activity as in normal animals could be achieved. In contrast to that, no similar increase of thrombopoietic activity was observed in nephrectomized animals after blood loss. According to the results of the authors the increase of thrombopoietic activity produced by different stimuli can be attributed to different mechanisms.